Screener
McKesson MCK Oncology & Multispecialty — Total other segment expense, net
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---|---|
| Total revenues | $105,380 | $97,827 |
| Other segment expense, net (2) | ||
| North American Pharmaceutical (3) | $85,870 | $82,135 |
| Oncology & Multispecialty | 13,897 | 10,446 |
| Prescription Technology Solutions (4) | 1,340 | 1,181 |
| Medical-Surgical Solutions (5) | 2,697 | 2,480 |
| Other | — | 292 |
| Total other segment expense, net | $103,804 | $96,534 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's oncology & multispecialty — total other segment expense, net?
- McKesson (MCK) reported oncology & multispecialty — total other segment expense, net of $13.9B in Q2 2026.
- How has McKesson's oncology & multispecialty — total other segment expense, net changed year-over-year?
- McKesson's oncology & multispecialty — total other segment expense, net increased by 33.0% year-over-year, from $10.45B to $13.9B.
- What is the long-term trend for McKesson's oncology & multispecialty — total other segment expense, net?
- Over 2 years (2024 to 2026), McKesson's oncology & multispecialty — total other segment expense, net has grown at a 26.0% compound annual growth rate (CAGR), from $29.78B to $47.27B.
- What does oncology & multispecialty — total other segment expense, net mean?
- Represents the net of miscellaneous operating expenses and income items not directly attributable to core segment operations within the Oncology and Multispecialty business unit. This figure captures non-operating costs, specific segment-level overheads, or unique adjustments that impact the segment's bottom line. It is used to reconcile segment operating profit to broader financial performance metrics.
Ask your AI about McKesson's oncology & multispecialty — total other segment expense, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude